logo-loader

Allergy Therapeutics PLC

Receive alerts
Market:
AIM
Market Cap:
£74.75 m
Price
11.75 GBX
Change
0.00%
52 weeks high
18.50
52 weeks low
8.00

In brief

We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.

Deep dive We explore the investor case for growth companies

Snapshot

The sell-off that followed the recent disappointment of Allergy’s PQ Birch jab means now might be a good time to invest, according to City broker finnCap